Treatment for Osteoporosis

Phase-Based Progress Estimates
Massachusetts General Hospital, Boston, MA
Osteoporosis+2 More
What conditions do you have?

Study Summary

Anabolic Therapy in Postmenopausal Osteoporosis

See full description

Eligible Conditions

  • Osteoporosis
  • Postmenopausal Osteoporosis

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome in patients with Osteoporosis. Measurement will happen over the course of Month 0 to 12.

Month 0 to 12
Total hip areal bone mineral density

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

1 of 2
Romosozumab and denosumab
1 of 2
Active Control

This trial requires 46 total participants across 2 different treatment groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 4 and have been shown to be safe and effective in humans.

Romosozumab and denosumab

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: month 0 to 12
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly month 0 to 12 for reporting.

Who is running the study

Principal Investigator
B. L.
Benjamin Leder, MD
Massachusetts General Hospital

Closest Location

Massachusetts General Hospital - Boston, MA

Eligibility Criteria

This trial is for female patients aged 18 and older. There is one eligibility criterion to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Postmenopausal women at high risk of fracture

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Osteoporosis by sharing your contact details with the study coordinator.